期刊文献+

肺腺鳞癌临床病理特点和外科治疗预后研究 被引量:4

The Clinic-pathologic Characteristics and the Surgical Prognosis in the Lung Adenosquamous Carcinoma Patients
下载PDF
导出
摘要 目的探讨影响肺腺鳞癌预后的因素,为改进治疗方案奠定基础。方法对361例肺腺鳞癌患者的临床资料进行回顾性分析。选择性别、年龄、症状、病程、肿瘤部位、X线分型、肿瘤边缘、分叶、密度、手术方法、胸膜皱缩、大体标本侵及胸膜或胸壁情况、手术性质、肿瘤最大直径、淋巴结转移模式、转移度(阳性淋巴结个数/淋巴结总数)、分化程度、病理侵及胸膜或胸壁情况、病理T项、病理N项、病理分期、术后放疗、术后化疗、术后复发转移等24个非重复因素进行预后分析,生存率计算采用寿命表法。统计分析运用Log-rank检验和Cox模型多因素分析。结果本组腺鳞癌根治术后的5年、10年生存率分别为29.1%和15.4%。Log-rank检验示X线分型、手术方法,大体标本侵及胸膜或胸壁情况,手术性质、肿瘤最大直径、病理侵及胸膜或胸壁情况、病理T项、病理N项、淋巴结转移模式、转移度、病理分期、术后复发转移及术后放疗对预后有显著影响(P<0.05)。经Cox多因素分析示术后复发转移、病理分期、手术性质因素对预后影响最大。结论肺腺鳞癌是一种生物学行为恶性程度较高的非小细胞肺癌,单纯外科治疗效果尚不满意。 Objective To investigate the clinic-pathologic characteristics and the prognostic factors in the patients with lung adenosquamous carcinoma. Methods The data of 361 patients operated for lung adenosquamous carcinoma were retrospectively analyzed as to the prognostic factors through comparison of survival rates by the actuarial method.A prognostic multivariable analysis was performed,after the variables related to prognosis were seeded with prognostic univariate analyses in the 24 non-repeating possible prog...
出处 《中国现代手术学杂志》 2009年第4期241-244,共4页 Chinese Journal of Modern Operative Surgery
关键词 肺肿瘤 腺鳞状 因素分析 统计学 lung neoplasms carcinoma adenosquamous factor analysis statistical
  • 相关文献

参考文献8

  • 1Pelletier MP,,Edwardes MD,Michel RP,et al.Prognostic markers inresectable non-small cell lung cancer:a multivariate analysis[].Canadian journal of Surgery.2001
  • 2Ichinose Y,Hara N,Takamori S,et al.DNA ploidy pattern ofeach carcinomatous component in adenosquamous lung carcino-ma[].The Annals of Thoracic Surgery.1993
  • 3Badzio A,Kurowski K,Karnicka-Mlodkowska H,et al.A ret-rospective comparative study of surgery followed by chemothera-py vs.non-surgical management in limited-disease small cell lungcancer[].European Journal of Cardio Thoracic Surgery.2004
  • 4N akagaw a K,Y asum itu T,Fukuhara K,et a l.Poor prognosisafter lung resection for patien ts w ith adenosquam ous carcinom aof the lung[].A nn Thorac Surg.2003
  • 5Jacek Gawrychowski Krzysztof Bruliki Eugeniusz Malinowski and Bolesw Papla.Prognosis and survival after radical resection of primary adenosquamous lung carcinoma[].European Journal of Cardio Thoracic Surgery.2005
  • 6Mountain CF.Revisions in the International System for Staging Lung Cancer[].Chest.1997
  • 7Belani CP.Adjuvant and neoadjuvant therapy in non-small cell lung cancer[].Seminars in Oncology.
  • 8Okada M,Nishio W,Sakamoto T,et al.Long-termsurvival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma[].Journal of Thoracic and Cardiovascular Surgery.2003

同被引文献34

  • 1Pirozynski M.100 years of lung cancer.Respir Med,2006,100:2073-2084.
  • 2Ishida T,Kaneko S,Yokoyama H,et al.Adenosquamous carcinoma of the lung.Clinicopathologic and immunohistochemical features.Am J Clin Pathol,1992,97:678-685.
  • 3Nakagawa K,Yasumitu T,Fukuhara K,et al.Poor prognosis after lung resection for patientswith adenosquamous carcinoma of the lung.Ann Thorac Surg,2003,75(6):1740-1744.
  • 4Hsia JY,Chen CY,Hsu CP,et al.Adenosquamous carcinoma of the lung.Surgical results compared with squamous cell and adenocarcinoma.Scand Cardiovasc J,1999,33:29-32.
  • 5Jia XL,Chen G.EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung.Lung Cancer,2011,74(3):396-400.
  • 6Shimizu J,Oda M,Hayashi Y et al.A clinicopathologic study of resected cases of adenosquamous carcinoma of the lung.Chest,1996,109(4):989-994.
  • 7Ichinose Y,Hara N,Takamori S,et al.DNA ploidy pattern of each carcinomatous componentin adenosquamous lung carcinoma.Ann Thorac Surg,1993,55(3):593-596.
  • 8Gawrychowski J,Bruliński K,Malinowski E,et al.Prognosis and survival after radical resection of primary adenosquamous lung carcinoma.Eur J Cardiothorac Surg,2005,27(4):686-692.
  • 9Maeda H,Matsumura A,Kawabata T,et al.Adenosquamous carcinoma of the lung:surgical results as compared with squamous cell and adenocarcinomab cases.Eur J Cardiothorac Surg,2012,41(2):357-361.
  • 10The International Adjuvant Lung Cancer Trial Collaborative Group.Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer.N Engl J Med,2004,350:351-360.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部